Skip to main content

Rensselaer Polytechnic Institute (RPI)

Understanding Heart Disease

October 2, 2017

Understanding Heart Disease

Rensselaer researchers are using Drosophilia to unravel mysteries of the human heart

The Center for Biotechnology and Interdisciplinary Studies was buzzing with activity over the summer, with more than 200 undergraduate and graduate students conducting research that will impact the global challenges facing humanity. In the lab of Douglas Swank, associate professor of biological sciences, researchers are using Drosophila (commonly known as the fruit fly) as a model organism to unravel some of the biggest mysteries of the human heart.

Swank has received funding from the National Institutes of Health to seek the molecular causes of hypertrophic cardiomyopathy, or enlarged heart disease. Using Drosophila enables Swank and his team to study aspects of the disease that cannot be studied in humans, other model organisms or cell culture.

“Our goal is to try to understand the molecular mechanism behind this disease so that we can help develop better treatments,” Swank said.

Pictured (l-r): Gemel Joseph, doctoral student in biological sciences; Amy Loya, doctoral student in biomedical engineering; Swank; and Kaylyn Bell, doctoral student in biochemistry and biophysics.

 

Contact

Reeve Hamilton
Director of Media Relations & Communications

(518) 833-4277
hamilr5@rpi.edu

For general inquiries: newsmedia@rpi.edu

About Rensselaer Polytechnic Institute

Founded in 1824, Rensselaer Polytechnic Institute is America’s first technological research university. Rensselaer encompasses five schools, 32 research centers, more than 145 academic programs, and a dynamic community made up of more than 7,900 students and more than 100,000 living alumni. Rensselaer faculty and alumni include more than 145 National Academy members, six members of the National Inventors Hall of Fame, six National Medal of Technology winners, five National Medal of Science winners, and a Nobel Prize winner in Physics. With nearly 200 years of experience advancing scientific and technological knowledge, Rensselaer remains focused on addressing global challenges with a spirit of ingenuity and collaboration.